New Chemical Entity
| out of 22 items. |
-
Ayala Pharmaceuticals
Targeted therapy oncology company -
Bsense Bio Therapeutics Ltd.
Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting... -
Concenter BioPharma
Developing Novel, First in Class Drug, Treating and Preventing Type 2 Diabetes, Based on a Core-Technology-Platform -
Ela Pharma
Elapharma is developing a new drug based on small Molecule for the inhibition of necrosis. Necrosis is the main mode of cell death and is associated... -
Vidac Pharma Ltd.
Vidac Pharma is a clinical-stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering... -
BioLineRx
BioLineRx (NASDAQ: BLRX; TASE: BLRX) is a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising... -
BioRest Ltd.
BioRest is developing a new therapy that directly targets proliferative monocytes with a liposome-housed bisphosphonate that can more effectively... -
BioSight
BioSight is a private biopharmaceutical company focused on research and development of innovative cancer targeted pro-drugs. BioSight has... -
D-Pharm Ltd
D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions.... -
Kamari Pharma
Kamari Pharma is a biopharmaceutical company aiming to develop and commercialize proprietary small molecule (SMC) inhibitors of TRPV3, a cation... -
Levation Pharma Ltd.
Levation Pharma is developing a novel product for the growing cash-pay prescription facial & eyelid aesthetic dermatology market. What Botox... -
Metallo Therapy
Metallo-Therapy is an early stage company focusing on improving cancer diagnostics and treatment. The Company specializes in developing products... -
Neurim Pharmaceuticals (1991) Ltd.
Neurim Pharmaeuticals is a drug discovery and development company focusing on CNS , particularly on diseases that are associated with sleep... -
NovoTyr Therapeutics Ltd.
NovoTyr discovered a novel proprietary family of small Mw inhibitors with unique mechanism, gaining long lasting anti-tumor effect. NovoTyr... -
Q2 Pharma Ltd.
Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) bacteria to be used in conjunction with commonly used... -
Se-cure Pharmaceuticals ltd.
Se-cure is a clinical stage & revenue generating, research-driven Israeli Pharmaceutical company, which has developed a proprietary platform... -
Semorex Technologies Ltd.
Diagnostic Kit for systemic fungal infection Dectection of toxic proteins using MIPs Developing a drug for treatment of cancer... -
Steba Laboratories Ltd
Steba Laboratories is focused on the development and GMP manufacturing of new drugs for the photodynamic treatment of cancer. -
SyndromeX
... -
Tarsius Pharma
... -
Tiltan Pharma Ltd.
Following an approval by the Israeli Ministry of Health, Tiltan Pharma has launched the Phase 2 study in major oncology centers in Israel: The... -
Vecoy Nanomedicines
Vecoy Nanomedicines Ltd is a BioPharma company that develops a new generation of nanomedicines for the treatment of HIV/AIDS, Hepatitis-C and...
| out of 22 items. |



